Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Marketing Data Collection on Use of ProSense® Cryoablation System With Adjuvant Endocrine Therapy for the Treatment of Patients With Low-Risk, Early-Stage Breast Cancer (ChoICE Trial)

NCT07629206 is registered in ClinicalTrials.gov with IceCure Medical Ltd. as lead sponsor.

NCT NCT07629206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07629206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Marketing Data Collection on Use of ProSense® Cryoablation System With Adjuvant Endocrine Therapy for the Treatment of Patients With Low-Risk, Early-Stage Breast Cancer (ChoICE Trial)
Lead sponsor
IceCure Medical Ltd.
Phase
Not applicable
Overall status
Recruiting
Start date
July 17, 2026
Completion date
September 30, 2034
Enrollment
400 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

low-risk, early stage breast cancer